Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Adcetris brentuximab vedotin: Interim Phase I data

Interim data from an open-label, dose-escalation, North American Phase I trial in 44 patients with newly diagnosed Hodgkin's lymphoma showed that Adcetris plus ABVD (adriamycin, bleomycin, vinblastine and dacarbazine) chemotherapy (n=25) led to complete remission

Read the full 351 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers